Targeting tumor O‐glycosylation modulates cancer–immune‐cell crosstalk and enhances anti‐PD‐1 immunotherapy in head and neck cancer.
- Resource Type
- Article
- Source
- Molecular Oncology; Feb2024, Vol. 18 Issue 2, p350-368, 19p
- Subject
- Language
- ISSN
- 15747891